Online Program

322787
Changes of Congenital Heart Disease Prevalence in the Korean Adults


Sunday, November 1, 2015

Shin Yi Jang, PhD, Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
Eun Young Ju, Graduate School of Public Health, Seoul National University, Seoul, Korea, Republic of (South)
Su Ra Seo, The National Health Insurance Corporation, Seoul, Korea, Republic of (South)
Ji Yeon Choi, Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
Chang Koan Lee, Science of Nursing, Korean Bible University, Seoul, Korea, Republic of (South)
Duk-Kyung Kim, PhD, MD, Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
Seung Woo Park, PhD, MD, Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
Purpose The aim of this study is to assess changes in the causes of congenital heart diseases between 2006 and 2013 in Korean adults.

Methods Data were collected from the National Health Insurance Corporation in Korea from 2006 through 2013. The data consisted of primary diagnoses related to congenital heart diseases diagnosed according to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD 10). Congenital heart disease included ventricular septal defect (Q21.00, Q21.01, Q21.08, Q21.09), atrial septal defect (Q21.18, 21.19), patent ductus arteriosus (Q25.0), stenosis of aorta (Q25.3), pulmonary artery stenosis (Q22.1, Q25.6), coarctation of aorta (Q25.1), tetralogy of fallot (Q21.3), ebstein anomaly (Q22.5), transposition of great arteries (Q20.3), eisenmenger syndrome (Q21.8), arterioventricular septal defect (Q21.2), pulmonary venous connection  (Q26.2, Q26.3, Q26.4), double outlet right ventricle (Q20.1), single ventricle (Q20.4), hypoplastic left heart syndrome (Q23.4), and atresia pulmonary artery (Q25.5). The age-standardized prevalence of congenital heart diseases in adults was calculated with the direct method using the estimated Korean population in 2010 as the reference.

Results Overall, the age-standardized cumulative prevalence of ventricular septal defect was 3.99 per 100,000 persons in 2011 and 4.25 in 2013. The age-standardized cumulative prevalence of atrial septal defect was 7.44 in 2011 and 8.54 in 2013. For female, the age-standardized cumulative prevalence of atrial septal defect was 10.31 in 2006 and 11.66 in 2013. The age-standardized cumulative prevalence of tetralogy of fallot was 0.84 in 2006 and 1.93 in 2013. The age-standardized cumulative prevalence of ebstein anomaly was 0.30 in 2006 and 0.54 in 2013. The age-standardized cumulative prevalence of double outlet right ventricle was 0.16 in 2006 and 0.30 in 2013. The age-standardized cumulative prevalence of single ventricle was 0.13 in 2006 and 0.38 in 2013. The age-standardized cumulative prevalence of patent ductus arteriosus, stenosis of aorta, pulmonary artery, coarctation of aorta, transposition of great arteries, eisenmenger syndrome, arterioventricular septal defect, pulmonary venous connection, double outlet right ventricle, single ventricle, hypoplastic left heart syndrome, and atresia pulmonary artery did not change dramatically between 2006 and 2013 year in adults.

Conclusions The overall age-standardized cumulative prevalence of ventricular septal defect, atrial septal defect, tetralogy of fallot, and ebstein anomaly increased between 2006 and 2013.

Learning Areas:

Chronic disease management and prevention
Epidemiology

Learning Objectives:
Demonstrate changes of congenital heart diseases prevalence between 2006 and 2013 in Korean adults.

Keyword(s): Heart Disease, Epidemiology

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I designed, analyzed, and wrote the manuscipt.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.